Pass the pot to Grandma — her brain might thank you. A new study is challenging long-held assumptions about cannabis, finding that middle-aged and older adults who use the drug may actually see some ...

Spousal benefits have some unique rules about claiming age and eligibility. You could be eligible for up to half your spouse's Social Security benefit. Understanding how your benefits could change as ...

New Delhi [India], February 11: Financial management, spending, payments, and security are all affected by the decision of whether one opts for a credit card or a debit card. While most people use ...

Plug-in air fresheners are a thing of the past. Nobody wants some fixture on the wall spraying toxic chemicals into their ...

Using tea tree oil may help control scalp oil production and promote healthy hair growth. Tea tree oil is potent, so it's important to dilute it before applying it to your scalp or hair. Ingesting tea ...

Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. Health care flexible spending accounts (FSAs) are a great way to use pre-tax dollars to pay for medical ...

At just over 5 foot, 5 inches, Christie Woodard weighs a lean 125 pounds. She's also open about relying on a low-dose GLP-1 to keep her weight there. She says sometimes people question why she's on ...

So thank you, everyone, for joining us in the room and online at TD Cowen's 46th Annual Healthcare Conference. I'm Joe Thome, one of the senior biotech analysts here on the team at TD Cowen. And it is ...

Elysse Bell is a finance and business writer for Investopedia. She writes about small business, personal finance, technology, and more. Dr. JeFreda R. Brown is a financial consultant, Certified ...

Well, good morning, everybody, and thank you once again for joining us for the 46th Annual TD Cowen Healthcare Conference. I'm Yaron Werber from the biotech team, and it's a great pleasure to moderate ...

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.